BIRC5 and cancer: The Survivin-specific siRNA reduced the levels of Survivin expression in the cells by greater than 90% (Figure 4B, panels labeled WCL) and, correspondingly, in the exosomes derived from the PTX-treated cancer cells (Figure 4B, panels labeled Exos).